Allarity Therapeutics wins Japanese patent for stenoparib diagnostic
The company said Japan's patent office granted a key patent for its stenoparib-specific DRP® companion diagnostic, extending protection in Japan into 2039.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The company said Japan's patent office granted a key patent for its stenoparib-specific DRP® companion diagnostic, extending protection in Japan into 2039.